Semaglutide stimulates insulin secretion and reduces glucagon secretion in a glucose-dependent manner, meaning the insulin response scales with how high blood glucose actually is
Tirzepatide produces 10 to 15 times more weight loss than AOD 9604 demonstrated in its best clinical trial
Peptides may one day prove to have legitimate clinical applications
Acknowledgements StarkAge Therapeutics is supported by the Deeptech Program from Banque Publique dInvestissement (France)
Thomas will present the findings at the following oral presentation session: Oral Presentations - Weighing Opportunities of Incretin-Based Therapy in Obesity Retatrutide, an Agonist of GIP, GLP-1, and Glucagon Receptors, Improves Markers of Pancreatic Beta-Cell Function and Insulin Sensitivity Presented on Sunday, June 23, 2024 at 2:45 PM EDT ### About the ADAs Scientific Sessions The ADA's 84th Scientific Sessions, the world's largest scientific meeting focused on diabetes research, prevention, and care, will be held in Orlando, FL on June 21-24